The Best of the Main Arena at SOLACI-SOCIME 2022: TAVR Complex Anatomy

In the transcatheter aortic valve replacement (TAVR) session we had a presentation by Dr. John P. Vavalle (USA), head of the Structural Heart Disease Program at the University of North Carolina at Chapel Hill. 

In his presentation, he showed how far the limits of percutaneous aortic valve implantation can be stretched by briefly showing successful cases:

  • A first case with a very large annulus >900 mm2 treated with a 29-mm Sapien S3 valve. 
  • A second case of pure aortic regurgitation without calcification in the annulus with implantation of a 26-mm S3 valve. 
  • A third case of extreme tortuosity with bilateral Lunderquist guidewire placement. He was able to perform the procedure with a long hydrophilic introducer and a snare advancement system. 
  • Dr. Vavalle closed the session with a case of very horizontal aorta in which he emphasized the importance of performing aggressive valvuloplasties and having deflectable delivery systems.

He later made a presentation on TAVR in bicuspid valves.

In this regard, he commented on the growth of the transcatheter strategy in bicuspid valve patients according to the TVT Registry.

Also, an analysis conducted by Dr. Makka et al showed that, compared with tricuspid valve patients, there were no differences in death, stroke, paravalvular leak or complications of the procedure, which evidences the efficacy of TAVR. Dr. Vavalle emphasized that these analyses included very select patients (with a very favorable anatomy for TAVR) that differ from those found in clinical practice. Consequently, he mentioned the importance of waiting for long-term results on this. 

The correct characterization of bicuspid valve anatomy is important, noting that those patients with calcified raphe and leaflets had much worse prognosis. We should always take into account the size and shape of the annulus, which is usually accompanied by low, anomalous coronary birth.

Afterwards, Dr. Jose Merino (MEX) spoke about TAVR in calcified annulus and analyzed the increased treatment complexity, observing complications such as paravalvular leak, conduction abnormalities, annulus rupture, and risk of coronary occlusion. 

How should we plan with a patient with severe valvular calcification? Evaluate the calcium load, its asymmetry, and extension both to the aortic root and the left ventricular outflow tract, as well as in the landing zone. 

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board of SOLACI.org.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TAVR Unload: TAVR in Moderate Aortic Stenosis and Ventricular Function Deterioration

Aortic Stenosis (AS) significantly contributes to valvulo-arterial impedance in patients with heart failure and reduced ejection fraction (HFrEF), making it a relevant therapeutic target...

TAVI and Hypertrophic Cardiomyopathy: An Increasingly Common Association

Stenosis is a common disease affecting 5% of the elderly population. It is associated with hospitalizations, poor quality of life, and mortality.  The association between...

TAVR in Bicuspid Valves: Higher Prosthesis Mismatch?

TAVR indication is steadily advancing onto younger, lower risk patients.  The presence of bicuspid aortic valves (BAV) has been observed in 0.5% to 2% of...

Edge-to-Edge Repair in Central and Non-Central Mitral Regurgitation

Mitral regurgitation (MR) is a common condition, with approximately 3.5% prevalence in individuals under 65, increasing to 7.7% in those over 75. It can...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Intravascular Lithotripsy in Calcified Coronary Lesions: Success Predictors

Coronary artery calcification (CAC) is increasingly common in patients undergoing percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL) has been established as an effective tool...

TAVR Unload: TAVR in Moderate Aortic Stenosis and Ventricular Function Deterioration

Aortic Stenosis (AS) significantly contributes to valvulo-arterial impedance in patients with heart failure and reduced ejection fraction (HFrEF), making it a relevant therapeutic target...

TAVI and Hypertrophic Cardiomyopathy: An Increasingly Common Association

Stenosis is a common disease affecting 5% of the elderly population. It is associated with hospitalizations, poor quality of life, and mortality.  The association between...